TSX Delisting Review - Appili Therapeutics Inc. (APLI)
| Issuer: | Appili Therapeutics Inc. (the "Company") |
| Securities: | Class A Common Shares |
| Symbol(s): | APLI |
| Delisting Review Type: | Remedial |
| Delisting Review Period: | TSX has decided to further extend its review of the eligibility of the Class A Common Shares of the Company for continued listing for a period of 30 days. |
| Additional Information: | Please refer to TSX Bulletin 2026-0679 dated July 9, 2026. |
| TSX Contact: | Anne Child, Managing Director, TSX Listings |
